The Patent Finder

Schwarz Pharma AG

Also on record
Records under this name other than patents Schwarz Pharma AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Schwarz Pharma AG

PatentTitleStatus Expires Confidence
US 7,670,621Transdermal Administration of (R)-3,3-Diphenylpropylamin-MONOESTERS
Formerly held
In force
 · High confidence
In forceHigh confidence
US 7,807,715Pharmaceutical compositions comprising fesoterodine
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,095,557Anticonvulsant combination therapy
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,446,011Anticonvulsant combination therapy
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,982,058Chiral intermediate, process for producing the same and its use in the manufacture of tolterodine, fesoterodine, or the active metabolite thereof
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,246,979Transdermal delivery system for the administration of rotigotine
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,088,398Pharmaceutical compositions comprising fesoterodine
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,501,723Pharmaceutical compositions comprising fesoterodine
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,044,0618-alkynylxanthines and derivatives
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,232,414Polymorphic form of rotigotine and process for production
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 85 patents shown.
Pro members see all 85.
Pro members: see all 85 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited